Corporate Profile

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

 

lnk Overview

Read More

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

lnk Stock Information

View All Stock Information

lnk Stock Information

View All Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

lnk Stock Information

View All Stock Information

News Releases

News and views about Intercure.

31-Aug-23

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

Achieved record revenues of NIS 209 million ($ 7 5 million) 1 for the first half of 2023 Annualized revenue run rate of NIS 41 7 million ($ 149 million) Adjusted EBITDA 2 of NIS 30 million ($ 11 million) Generated NIS 35 million ($ 13 million) cash from operations in the second quarter Strong
10-Jul-23

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

NEW YORK and TORONTO and HERZLIYA, Israel, July 10, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(" InterCure " or the " Compan y "), announced today that its board of directors (“ Board ”) has approved the voluntarily delisting of the Company’s
09-Jun-23

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

NEW YORK and TORONTO and HERZLIYA, Israel, June 09, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(" InterCure " or the " Compan y "), reports today that, further to the Company’s press release issued on February 1, 2023, where the Company had

lnk News

Events
Investor events will be posted soon.

lnk Events

View All Events
Featured Reports
Aug 16, 2022